| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 3 | |
| #2 | Australia | 2 | |
| #3 | Canada | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | Brazil | 1 | |
| #6 | Mexico | 1 | |
| #7 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Fujimoto Takashi | 10 |
| #2 | Okazaki Kimiya | 10 |
| #3 | Yoshizawa Eiko | 9 |
| #4 | Kase Koichiro | 9 |
| #5 | Shibahara Takeshi | 9 |
| #6 | Kami Hiroshi | 8 |
| #7 | Ichikawa Hideki | 2 |
| #8 | Mikami Yoshitaka | 2 |
| #9 | Fukumori Yoshinobu | 2 |
| #10 | Kami Hiroshima | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO9824410A2 | Controlled release matrix tablet and method for its preparation | |
| EP0978281A1 | Eyedrops containing a loratidine metabolite | |
| BR9611342A | Ophthalmic solution. | |
| ZA9608943B | Ophthalmic solution |